Have a personal or library account? Click to login
Pathophysiology of paraneoplastic rheumatologic syndromes- could be involved in the diagnosis of a pulmonary adenocarcinoma? Cover

Pathophysiology of paraneoplastic rheumatologic syndromes- could be involved in the diagnosis of a pulmonary adenocarcinoma?

Open Access
|Jun 2024

References

  1. Hakkou, Jinane et al. “Paraneoplastic rheumatic syndromes: report of eight cases and review of literature.” Rheumatology international vol. 32,6 (2012): 1485-9. doi:10.1007/s00296-011-2252-9.
  2. Pelosof LC, Gerber DE (2010) Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment. Mayo Clin Proc 85: 838–854.
  3. Bergman PJ (2012) Paraneoplastic Hypercalcemia. Topics in Companion Animal Medicine 27:156–158.
  4. Al Khayyat SG, Conticini E, Falsetti P, Gentileschi S, Vitale A, Stella SM, D’Alessandro M, Bargagli E, Cantarini L, Frediani B (2022) Paraneoplastic arthritides: an up-to-date case-based systematic review. Reumatologia 60:422–436.
  5. Titulaer MJ, Soffietti R, Dalmau J, et al. (2011) Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force. Eur J Neurol 18:19-e3.
  6. Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T, Dobashi H, Matsunaga T (2014) Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol 5:197–223.
  7. Darnell RB, Posner JB (2006) Paraneoplastic syndromes affecting the nervous system. Semin Oncol 33:270–298.
  8. Yoo KH, Rho YK, Kim JY, Li K, Seo SJ, Hong CK (2009) Cutaneous Paraneoplastic Syndrome in a Patient With Adenocarcinoma of Unknown Primary Site Syndrome. JCO 27:309–311.
  9. Y Ü, A D (2022) Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients. European journal of gastroenterology & hepatology. https://doi.org/10.1097/MEG.0000000000002341.
  10. Marsalisi, Christopher et al. “Paraneoplastic Scleroderma: A Case Report of Systemic Sclerosis in the Setting of Pulmonary Adenocarcinoma.” Cureus vol. 15,3 e36366. 19 Mar. 2023, doi:10.7759/cureus.36366.
  11. Fam AG (2000) Paraneoplastic rheumatic syndromes. Best Practice & Research Clinical Rheumatology 14:515–533.
  12. Yu H, Fu R, Wang H, Liu H, Shao Z (2017) Paraneoplastic Evans syndrome in a patient with adenocarcinoma of the lung: A case report. Thorac Cancer 8:57–60.
  13. Racanelli V, Prete M, Minoia C, Favoino E, Perosa F (2008) Rheumatic disorders as paraneoplastic syndromes. Autoimmunity Reviews 7:352–358.
  14. Fam AG (2000) Paraneoplastic rheumatic syndromes. Best Practice & Research Clinical Rheumatology 14:515–533.
  15. Lei, Y., Liu, C., Wan, X. et al. Polymyositis as a paraneoplastic syndrome of a patient with primary pulmonary lymphoepithelioma-like carcinoma: a case report and literature review. J Cardiothorac Surg 17, 120 (2022). https://doi.org/10.1186/s13019-022-01860-4.
  16. Wen J, Ouyang H, Yang R, Bo L, Zhang Y, Tang M, Liu Z (2018) Malignancy dominated with rheumatic manifestations: A retrospective single-center analysis. Sci Rep. https://doi.org/10.1038/s41598-018-20167-w.
  17. Epelbaum O, Rahman NM (2019) Contemporary approach to the patient with malignant pleural effusion complicating lung cancer. Ann Transl Med. https://doi.org/10.21037/atm.2019.03.614.
  18. Travis WD, Brambilla E, Nicholson AG, et al (2015) The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol 10:1243–1260.
  19. McClelland MT (2010) Paraneoplastic Syndromes Related to Lung Cancer. Clinical Journal of Oncology Nursing 14:357–364.
  20. Spiro SG, Gould MK, Colice GL, American College of Chest Physicians (2007) Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132:149S-160S.
  21. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al.Frequency of specific cancer types in dermatomyositis and polymyositis:a population-based study. Lancet. 2001;357(9250):96–100.
  22. Dumansky YV, Syniachenko OV, Stepko PA, Yehudina YD, Stoliarova OY. Paraneoplastic syndrome in lung cancer. Exp Oncol. 2018;40(3):239–242.
  23. Wilkins CM, Johnson VL, Fargason RE, Birur B. Psychosis as a sequelae of paraneoplastic syndrome in small-cell lung carcinoma: A psycho-neuroendocrine interface. Clin Schizophr Relat Psychoses 2017; 22: 153–8.
  24. Kisacik B, Onat AM, Kasifoglu T, et al (2014) Diagnostic dilemma of paraneoplastic arthritis: case series. Int J Rheum Dis 17:640–645.
  25. Thomas L, Kwok Y, Edelman MJ (2004) Management of paraneoplastic syndromes in lung cancer. Curr Treat Options Oncol 5:51–62.
  26. Todea D, Cosma C, Dicu T, Rosca L, Dinu AC, Risteiu M, Iancu D, Papuc I, Radulescu D (2013) Lung cancer risk induced by residential radon in cluj and alba counties, romania. Environmental Engineering and Management Journal 12:1281–1285.
  27. Nawata T, Kubo M, Mitsui H, Oishi K, Omoto M, Kanda T, Yano M (2018) Dermatomyositis Complicated by Digital Ischemia and Lung Adenocarcinoma in a Patient with Positive Anti-signal Recognition Particle Antibodies. Intern Med 57:883–886.
  28. Khan, Fahad et al. “Paraneoplastic Musculoskeletal Syndromes.” Rheumatic diseases clinics of North America vol. 46,3 (2020): 577-586. doi:10.1016/j.rdc.2020.04.002.
  29. Gamage KKK, Rifath MIM, Fernando H. Migratory polyarthritis as a paraneoplastic syndrome in a patient with diffuse large B cell lymphoma: a case report. J Med Case Rep 2018;12(1):189.
  30. Yu K-H, Kuo C-F, Huang LH, Huang W-K, See L-C (2016) Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases. Medicine (Baltimore) 95:e3540.
  31. Rugienė R, Dadonienė J, Aleknavičius E, Tikuišis R, Distler J, Schett G, Venalis P, Venalis A (2011) Prevalence of paraneo-plastic rheumatic syndromes and their antibody profile among patients with solid tumours. Clin Rheumatol 30:373–380.
  32. Naschitz JE, Rosner I, Rozenbaum M, Zuckerrnan E, Yeshurun D Rheumatic Syndromes: Clues to Occult Neoplasia. 13.
  33. Rovisco J, Serra S, Abreu P, Coutinho M, Santiago T, Inês L, da Silva JAP (2014) Paraneoplastic sclerodermiform syndrome-case report. Acta Reumatol Port 39:87–90.
  34. H O, H I, D Y, M M (2022) Palmar Fasciitis and Polyarthritis Syndrome Associated with Lung Adenocarcinoma. Internal medicine (Tokyo, Japan). https://doi.org/10.2169/internalmedicine.8619-21.
  35. Le Besnerais, Maëlle et al. “Digital ischemia associated with cancer: results from a cohort study.” Medicine vol. 93,10 (2014): e47. doi:10.1097/MD.0000000000000047.
  36. Dorronsoro Martín I, Merino Muñoz R, Sastre-Urguellés A, García-Miguel García-Rosado P, García-Consuegra Molina J (2004) Manifestaciones reumáticas como forma de comienzo de enfermedad maligna. Anales de Pediatría 61:393–397.
  37. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100.
  38. Characteristics of 10 patients with paraneoplastic rheumato-logic musculoskeletal manifestations: Modern Rheumatology: Vol 24, No 3. https://www.tandfonline.com/doi/abs/10.3109/14397595.2013.843762?journalCode=imor20. Accessed 3 Nov 2021.
  39. Stummvoll GH, Aringer M, Machold KP, Smolen JS, Raderer M (2001) Cancer polyarthritis resembling rheumatoid arthritis as a first sign of hidden neoplasms. Report of two cases and review of the literature. Scand J Rheumatol 30:40–44.
  40. Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 17:212.
  41. Hong X, Wang L, Zhang K, Liu J, Liu J-P (2022) Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis. Cells 11:877.
  42. Silvério-António M, Parlato F, Martins P, Khmelinskii N, Braz S, Fonseca JE, Polido-Pereira J (2021) Gastric Adenocarcinoma Presenting as a Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibody-Positive Polyarthritis: A Case Report and Review of Literature. Front Med (Lausanne) 8:627004.
  43. Palakkuzhiyil N, Namitha R, Rakhesh SV, Thomas R, Uvais NA (2019) Dermatomyositis associated with adenocarcinoma of the lung: A case report. J Family Med Prim Care 8:754–756.
  44. Palakkuzhiyil, Naseem et al. “Dermatomyositis associated with adenocarcinoma of the lung: A case report.” Journal of family medicine and primary care vol. 8,2 (2019): 754-756. doi:10.4103/jfmpc.jfmpc_467_18.
  45. Eidenschink M, Beard A, Ewart D (2019) Paraneoplastic Migratory Oligoarthritis in a Patient With Malignant Mesothelioma. Am J Med 132:e801–e802.
  46. Park DW, Choi J, Chung SJ, Park TS, Lee H, Moon J-Y, Kim S-H, Kim T-H, Yoon HJ, Sohn JW (2020) The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis. Transl Cancer Res 9:2627–2637.
  47. Manger B, Schett G (2014) Paraneoplastic syndromes in rheumatology. Nat Rev Rheumatol 10:662–670.
  48. Poddar K, Pathikonda L, Villamil M Sudden onset polyarthritis as a paraneoplastic syndrome from non-small cell lung cancer. J Community Hosp Intern Med Perspect 10:174–178.
DOI: https://doi.org/10.2478/pneum-2024-0001 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Language: English
Page range: 1 - 6
Published on: Jun 10, 2024
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2024 Corina Eugenia Budin, Dariana Elena Pătrîntașu, Sárközi Hédi-Katalin, Iuliu Gabriel Cocuz, Edith Simona Ianoși, Ovidiu Simion Cotoi, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.